SARS-CoV-2

The U.S. Food and Drug Administration (FDA) may approve updated COVID-19 vaccines this week to combat recent strains as the country endures its most significant summer outbreak in two years. The FDA is expected to give the nod to updated mRNA vaccines from Moderna, Inc. (NASDAQ:MRNA) and Pfizer Inc...

In a recent study conducted by researchers at Dalhousie University in Canada, cannabis and its compounds have emerged as potential allies in the fight against COVID-19. Published in the Journal of Clinical Medicine, the study explored the preventive and therapeutic capabilities of cannabinoids in...

Pfizer Inc (NYSE: PFE) says it has begun late-stage testing for an oral drug that can be taken by persons who are exposed to the virus that causes COVID-19. What Happened: The New York-based drugmaker said Monday it has commenced a new large study that will evaluate a novel protease inhibitor...

Augmenta Bioworks and TFF Pharmaceuticals Inc (NASDAQ: TFFP) have announced positive in vitro data indicating that their lead anti-COVID-19 monoclonal antibody, AUG-3387, binds to and neutralizes the SARS-CoV-2 Delta variant (B.1.617.2).  The companies have selected a...

Cocrystal Pharma Inc (NASDAQ: COCP) announces that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed potent in vitro activity against the SARS-CoV-2 Delta (India/B.1.617.2) and Gamma (Brazil/P.1) variants.  "Our next steps are to scale-up synthesis and...

Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) cemented their lead in the coronavirus vaccine race by beginning the rolling submission of the regulatory application in Europe. What Happened: The U.S.-German collaborators announced Tuesday they have initiated a rolling...